<VariationArchive RecordType="classified" VariationID="18397" VariationName="NM_002036.4(ACKR1):c.286_299del (p.Trp96fs)" VariationType="Deletion" Accession="VCV000018397" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-08-12" MostRecentSubmission="2015-08-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="33436" VariationID="18397">
      <GeneList>
        <Gene Symbol="ACKR1" FullName="atypical chemokine receptor 1 (Duffy blood group)" GeneID="2532" HGNC_ID="HGNC:4035" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="159204875" stop="159206500" display_start="159204875" display_stop="159206500" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="159173802" stop="159176289" display_start="159173802" display_stop="159176289" Strand="+" />
          </Location>
          <OMIM>613665</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002036.4(ACKR1):c.286_299del (p.Trp96fs)</Name>
      <CanonicalSPDI>NC_000001.11:159205718:CCTGGCTGGCCTGTCCTGGC:CCTGGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="159205719" stop="159205732" display_start="159205719" display_stop="159205732" variantLength="14" positionVCF="159205718" referenceAlleleVCF="CCCTGGCTGGCCTGT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="159175509" stop="159175522" display_start="159175509" display_stop="159175522" variantLength="14" positionVCF="159175508" referenceAlleleVCF="CCCTGGCTGGCCTGT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>ACKR1, 14-BP DEL, NT286</Name>
      </OtherNameList>
      <ProteinChange>W96fs</ProteinChange>
      <ProteinChange>W98fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_801" sequenceAccession="LRG_801">
            <Expression>LRG_801:g.6713_6726del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_801t1" sequenceAccession="LRG_801t1">
            <Expression>LRG_801t1:c.286_299del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_801p1" sequenceAccession="LRG_801p1" change="p.Trp96fs">
            <Expression>LRG_801p1:p.Trp96fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.159175515_159175528del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.159175515_159175528del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.159205725_159205738del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.159205725_159205738del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011626.3" sequenceAccession="NG_011626" sequenceVersion="3" change="g.6713_6726del">
            <Expression>NG_011626.3:g.6713_6726del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122951.3" sequenceAccession="NM_001122951" sequenceVersion="3" change="c.292_305del">
            <Expression>NM_001122951.3:c.292_305del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116423.1" sequenceAccession="NP_001116423" sequenceVersion="1" change="p.Trp98fs">
            <Expression>NP_001116423.1:p.Trp98fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002036.4" sequenceAccession="NM_002036" sequenceVersion="4" change="c.286_299del" MANESelect="true">
            <Expression>NM_002036.4:c.286_299del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002027.2" sequenceAccession="NP_002027" sequenceVersion="2" change="p.Trp96fs">
            <Expression>NP_002027.2:p.Trp96fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613665.0004" DB="OMIM" />
        <XRef Type="rs" ID="587776507" DB="dbSNP" />
        <XRef ID="CA113791" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002036.4(ACKR1):c.286_299del (p.Trp96fs) AND DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE" Accession="RCV000000010" Version="3">
        <ClassifiedConditionList TraitSetID="6212">
          <ClassifiedCondition>DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-08-12" MostRecentSubmission="2015-08-12">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10791881</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7669660</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8248172</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8547665</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6212" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15692" Type="BloodGroup">
              <Name>
                <ElementValue Type="Alternate">DUFFY NULL; Fy(a-b-)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE</ElementValue>
                <XRef Type="Allelic variant" ID="613665.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613665.0002" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20153" SubmissionDate="2015-08-10" DateLastUpdated="2015-08-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613665.0004_DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE" title="ACKR1, 14-BP DEL, NT286_DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE" />
        <ClinVarAccession Accession="SCV000020153" DateUpdated="2015-08-12" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Mallinson et al. (1995) presented evidence for 2 different genetic backgrounds giving rise to the Fy(a-b-) phenotype. The most likely genetic mechanism in most individuals is downregulation of Duffy glycoprotein mRNA (see 613665.0002). However, the Duffy gene from a very rare Caucasian individual (AZ) with the Fy(a-b-) phenotype had a 14-bp deletion that resulted in a frameshift. In the Abstract and Results sections of their paper, Mallinson et al. (1995) reported that the deletion removed nucleotides 287 to 301 of DARC. However, their Figure 4 showed that the deletion involved nucleotides 292 to 305, which appeared to be correct. The DARC cDNA sequence used by Mallinson et al. (1995) was identical to that of the minor DARC variant reported by Chaudhuri et al. (1993). The frameshift resulting from the deletion introduced a stop codon 23 amino acids downstream and produced a putative truncated 118-amino acid protein. The occurrence of this mutation in an apparently healthy individual raised questions about the functional importance of the Duffy glycoprotein, not only in normal erythrocytes, but also in all human cells and tissues. The only known examples of the Fy(a-b-) phenotype in Caucasians were AZ and Czech gypsies.</Attribute>
              <Citation>
                <ID Source="PubMed">7669660</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8248172</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using the sequence of the major DARC variant reported by Iwamoto et al. (1996), as was recommended by Pogo and Chaudhuri (2000), this 14-bp deletion occurs at nucleotide 286.</Attribute>
              <Citation>
                <ID Source="PubMed">8547665</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10791881</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACKR1" />
          </GeneList>
          <Name>ACKR1, 14-BP DEL, NT286</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">14-BP DEL, NT286</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613665.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20153" TraitType="Disease" MappingType="Name" MappingValue="DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE" MappingRef="Preferred">
        <MedGen CUI="C4017326" Name="DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

